SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

Vielight Neuro RX Gamma device and irradiation configuration used in the randomized, double-blind, sham-controlled trial.

Invivyd's SPEAR Study Group will investigate PEMGARDA®'s efficacy in treating Long COVID and Post-Vaccination Syndrome through monoclonal antibody therapy. Invivyd, Inc. has established the SPEAR ...

Samantha Chatman (WLS) -- While many people are finding ways to manage the effects of COVID-19, others are finding it hard to cope with this new normal. With so much uncertainty, local therapists are ...

High-titre convalescent plasma therapy given within a week of symptom onset reduced hospitalisation and death and was well tolerated in immunocompromised patients with mild COVID-19. This randomised ...

MIDDLEBURG, Va. — For Tom Sweitzer, music is a part of his personal and professional life. “I'm a certified music therapist,” he said. Sweitzer co-founded “A Place To Be,” a nonprofit in Virginia that ...

Even as the acute phase of the COVID-19 pandemic fades, the world continues to wrestle with its aftermath — and nowhere is that more evident than in the enduring challenge of Long COVID. The condition ...

Larazotide, an oral drug, may effectively treat MIS-C by tightening the gut epithelial barrier, reducing systemic inflammation. The phase 2a trial showed faster resolution of GI symptoms and spike ...